Back to 
M&G Plc
M&G Plc
BRNS
11 quarters
Position history for M&G Plc's holdings in BARINTHUS BIOTHERAPEUTICS PL
No. M&G exited its BRNS (Barinthus Biotherapeutics PL) position in Q3 2026. Its Q2 2026 13F listed 5,197,349 shares worth $5.2M. M&G already held BRNS in its Q1 2024 13F, the earliest on record, and held it in 10 quarterly 13F filings.
Final Value
$0
Final Shares
0
Total Value Change
-$10.4M
Total Shares Change
-5.2M
Quarter-by-Quarter History
Other major holders of BRNS: Alphabet Inc.